Skip to main content
Top
Published in: Radiation Oncology 1/2012

Open Access 01-12-2012 | Research

Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas

Authors: Colin E Champ, Joshua Siglin, Mark V Mishra, Xinglei Shen, Maria Werner-Wasik, David W Andrews, Sonal U Mayekar, Haisong Liu, Wenyin Shi

Published in: Radiation Oncology | Issue 1/2012

Login to get access

Abstract

Background

Adjuvant radiation therapy (RT) with temozolomide (TMZ) is standard of care for high grade gliomas (HGG) patients. RT is commonly started 3 to 5 weeks after surgery. The deformation of the tumor bed and brain from surgery to RT is poorly studied. This study examined the magnitude of volume change in the postoperative tumor bed and the potential impact of RT planning.

Method and materials

This study includes 24 patients with HGG who underwent craniotomy and adjuvant RT with TMZ at our institution. All patients had immediate postoperative MRI and repeat MRI during the day of RT simulation. Gross tumor volumes (GTV), clinical target volumes (CTV) of initial 46 Gy (CTV1) and boost to 60 Gy (CTV2) were contoured on both sets of MRIs according to RTOG (Radiation Therapy Oncology Group) guidelines. For patients who recurred after RT, the recurrence pattern was evaluated.

Results

An average of 17 days elapsed between immediate and delayed MRIs. GTV1 (FLAIR abnormality and tumor bed) decreased significantly on the delayed MRI as compared to immediate post-operative MRI (mean = 30.96cc, p = 0.0005), while GTV2 (contrast-enhanced T1 abnormality and tumor bed) underwent a non-significant increase (mean = 6.82cc, p = 0.07). Such changes lead to significant decrease of CTV1 (mean decrease is 113.9cc, p<0.01), and significant increase of CTV2 (mean increase is 32.5cc, p=0.05). At a median follow-up of 13 months, 16 patients (67%) progressed, recurred, or died, with a progression-free survival time of 13.7 months. Twelve patients failed within all CTVs based on immediate and delayed MRIs, while one patient recurred outside of CTV2 based on immediate post-operative MRI, but within the CTV2 defined on delayed MRI.

Conclusion

The postoperative tumor bed of HGGs undergoes substantial volumetric changes after surgery. Treatment planning based on delayed MRI significantly reduces the volume of treated brain tissue without local control detriment. The marked reduction of volume treated to 46 Gy based on delayed MRI scan, could result in increased sparing of organs at risk. There may be a small risk of inadequate radiation field design if radiation planning is based on immediate post-operative MRI.
Appendix
Available only for authorised users
Literature
2.
go back to reference Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008, 62: 753-764. discussion 264-756 10.1227/01.neu.0000318159.21731.cfCrossRefPubMed Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008, 62: 753-764. discussion 264-756 10.1227/01.neu.0000318159.21731.cfCrossRefPubMed
3.
go back to reference Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 2008, 359: 492-507. 10.1056/NEJMra0708126CrossRefPubMed Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 2008, 359: 492-507. 10.1056/NEJMra0708126CrossRefPubMed
4.
go back to reference Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352: 987-996. 10.1056/NEJMoa043330CrossRefPubMed Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352: 987-996. 10.1056/NEJMoa043330CrossRefPubMed
5.
go back to reference Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J Jr, Strike TA, et al.: Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989, 71: 1-9. 10.3171/jns.1989.71.1.0001CrossRefPubMed Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J Jr, Strike TA, et al.: Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989, 71: 1-9. 10.3171/jns.1989.71.1.0001CrossRefPubMed
6.
go back to reference Garden AS, Maor MH, Yung WK, Bruner JM, Woo SY, Moser RP, Lee YY: Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991, 20: 99-110. 10.1016/0167-8140(91)90143-5CrossRefPubMed Garden AS, Maor MH, Yung WK, Bruner JM, Woo SY, Moser RP, Lee YY: Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991, 20: 99-110. 10.1016/0167-8140(91)90143-5CrossRefPubMed
7.
go back to reference Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989, 16: 1405-1409. 10.1016/0360-3016(89)90941-3CrossRefPubMed Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989, 16: 1405-1409. 10.1016/0360-3016(89)90941-3CrossRefPubMed
8.
go back to reference Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M: 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 1999, 53: 53-57. 10.1016/S0167-8140(99)00117-6CrossRefPubMed Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M: 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 1999, 53: 53-57. 10.1016/S0167-8140(99)00117-6CrossRefPubMed
9.
go back to reference Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler HM: Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002, 20: 1635-1642. 10.1200/JCO.20.6.1635CrossRefPubMed Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler HM: Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002, 20: 1635-1642. 10.1200/JCO.20.6.1635CrossRefPubMed
10.
go back to reference RTOG 0825: Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma. 2011.http://www.rtog.org Accessed April 5, 2011, at RTOG 0825: Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma. 2011.http://​www.​rtog.​org Accessed April 5, 2011, at
11.
go back to reference McDonald MW, Shu H-KG, Curran WJ, Crocker IR: Pattern of Failure After Limited Margin Radiotherapy and Temozolomide for Glioblastoma. International journal of radiation oncology, biology, physics 2011, 79: 130-136. 10.1016/j.ijrobp.2009.10.048CrossRefPubMed McDonald MW, Shu H-KG, Curran WJ, Crocker IR: Pattern of Failure After Limited Margin Radiotherapy and Temozolomide for Glioblastoma. International journal of radiation oncology, biology, physics 2011, 79: 130-136. 10.1016/j.ijrobp.2009.10.048CrossRefPubMed
12.
go back to reference Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, Famiglietti R, Allen PK, Chao KSC, Mahajan A, et al.: Evaluation of Peritumoral Edema in the Delineation of Radiotherapy Clinical Target Volumes for Glioblastoma. International Journal of Radiation Oncology*Biology*Physics 2007, 68: 144-150. 10.1016/j.ijrobp.2006.12.009CrossRef Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, Famiglietti R, Allen PK, Chao KSC, Mahajan A, et al.: Evaluation of Peritumoral Edema in the Delineation of Radiotherapy Clinical Target Volumes for Glioblastoma. International Journal of Radiation Oncology*Biology*Physics 2007, 68: 144-150. 10.1016/j.ijrobp.2006.12.009CrossRef
13.
go back to reference Dillon WP: Imaging of central nervous system tumors. Curr Opin Radiol 1991, 3: 46-50.PubMed Dillon WP: Imaging of central nervous system tumors. Curr Opin Radiol 1991, 3: 46-50.PubMed
14.
go back to reference Castillo M: Contrast enhancement in primary tumors of the brain and spinal cord. Neuroimaging Clin N Am 1994, 4: 63-80.PubMed Castillo M: Contrast enhancement in primary tumors of the brain and spinal cord. Neuroimaging Clin N Am 1994, 4: 63-80.PubMed
15.
go back to reference Bronen RA, Sze G: Magnetic resonance imaging contrast agents: theory and application to the central nervous system. J Neurosurg 1990, 73: 820-839. 10.3171/jns.1990.73.6.0820CrossRefPubMed Bronen RA, Sze G: Magnetic resonance imaging contrast agents: theory and application to the central nervous system. J Neurosurg 1990, 73: 820-839. 10.3171/jns.1990.73.6.0820CrossRefPubMed
16.
go back to reference Iuchi T, Hatano K, Kodama T, Tohyama N, Kojima T, Sakaida T, Kawasaki K, Hasegawa Y: Brain Deformation after Planning for IMRT may Affect the Outcome of Patients with Glioblastoma. International journal of radiation oncology, biology, physics 2010, 78: S278-S279.CrossRef Iuchi T, Hatano K, Kodama T, Tohyama N, Kojima T, Sakaida T, Kawasaki K, Hasegawa Y: Brain Deformation after Planning for IMRT may Affect the Outcome of Patients with Glioblastoma. International journal of radiation oncology, biology, physics 2010, 78: S278-S279.CrossRef
17.
go back to reference Shukla D, Huilgol NG, Trivedi N, Mekala C: T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomas. J Cancer Res Ther 2005, 1: 235-238. 10.4103/0973-1482.19601CrossRefPubMed Shukla D, Huilgol NG, Trivedi N, Mekala C: T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomas. J Cancer Res Ther 2005, 1: 235-238. 10.4103/0973-1482.19601CrossRefPubMed
18.
go back to reference Tsien C, Gomez-Hassan D, Ten Haken RK, Tatro D, Junck L, Chenevert TL, Lawrence T: Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys 2005, 62: 328-332. 10.1016/j.ijrobp.2004.10.010CrossRefPubMed Tsien C, Gomez-Hassan D, Ten Haken RK, Tatro D, Junck L, Chenevert TL, Lawrence T: Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys 2005, 62: 328-332. 10.1016/j.ijrobp.2004.10.010CrossRefPubMed
19.
go back to reference Manon R, Hui S, Chinnaiyan P, Suh J, Chang E, Timmerman R, Phan S, Das R, Mehta M: The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme. Technol Cancer Res Treat 2004, 3: 303-307.CrossRefPubMed Manon R, Hui S, Chinnaiyan P, Suh J, Chang E, Timmerman R, Phan S, Das R, Mehta M: The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme. Technol Cancer Res Treat 2004, 3: 303-307.CrossRefPubMed
20.
go back to reference Forsyth PA, Petrov E, Mahallati H, Cairncross JG, Brasher P, MacRae ME, Hagen NA, Barnes P, Sevick RJ: Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 1997, 15: 2076-2081.PubMed Forsyth PA, Petrov E, Mahallati H, Cairncross JG, Brasher P, MacRae ME, Hagen NA, Barnes P, Sevick RJ: Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 1997, 15: 2076-2081.PubMed
Metadata
Title
Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas
Authors
Colin E Champ
Joshua Siglin
Mark V Mishra
Xinglei Shen
Maria Werner-Wasik
David W Andrews
Sonal U Mayekar
Haisong Liu
Wenyin Shi
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2012
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-7-220

Other articles of this Issue 1/2012

Radiation Oncology 1/2012 Go to the issue